CN114057699B - 一种伏立康唑中间体外消旋体的制备方法 - Google Patents
一种伏立康唑中间体外消旋体的制备方法 Download PDFInfo
- Publication number
- CN114057699B CN114057699B CN202110789834.5A CN202110789834A CN114057699B CN 114057699 B CN114057699 B CN 114057699B CN 202110789834 A CN202110789834 A CN 202110789834A CN 114057699 B CN114057699 B CN 114057699B
- Authority
- CN
- China
- Prior art keywords
- difluorophenyl
- butanol
- triazole
- formate
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 title claims abstract description 15
- 229960004740 voriconazole Drugs 0.000 title claims abstract description 15
- 238000000338 in vitro Methods 0.000 title description 3
- 238000006243 chemical reaction Methods 0.000 claims abstract description 21
- BQDLXFABVRRDFU-UHFFFAOYSA-N 3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(C)C1=NC=NC(Cl)=C1F BQDLXFABVRRDFU-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000047 product Substances 0.000 claims abstract description 15
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims abstract description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 12
- 238000003756 stirring Methods 0.000 claims abstract description 11
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims abstract description 10
- 239000004280 Sodium formate Substances 0.000 claims abstract description 10
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 150000007524 organic acids Chemical class 0.000 claims abstract description 10
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 claims abstract description 10
- 235000019254 sodium formate Nutrition 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 7
- 238000001816 cooling Methods 0.000 claims abstract description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000008213 purified water Substances 0.000 claims description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 239000012065 filter cake Substances 0.000 claims description 14
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 5
- 238000007605 air drying Methods 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- 238000004537 pulping Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 5
- 239000006227 byproduct Substances 0.000 abstract description 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 5
- 239000001257 hydrogen Substances 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 8
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 231100000024 genotoxic Toxicity 0.000 description 3
- 230000001738 genotoxic effect Effects 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- BCEHBSKCWLPMDN-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical group C1=NC=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(C)C1=NC=NC=C1F BCEHBSKCWLPMDN-UHFFFAOYSA-N 0.000 description 1
- ISUMRMYBGZGUMY-UHFFFAOYSA-N 3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-ol;hydrochloride Chemical compound Cl.C1=NC=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(C)C1=NC=NC(Cl)=C1F ISUMRMYBGZGUMY-UHFFFAOYSA-N 0.000 description 1
- -1 33.5 kg) Chemical compound 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110789834.5A CN114057699B (zh) | 2021-07-13 | 2021-07-13 | 一种伏立康唑中间体外消旋体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110789834.5A CN114057699B (zh) | 2021-07-13 | 2021-07-13 | 一种伏立康唑中间体外消旋体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114057699A CN114057699A (zh) | 2022-02-18 |
CN114057699B true CN114057699B (zh) | 2024-05-10 |
Family
ID=80233298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110789834.5A Active CN114057699B (zh) | 2021-07-13 | 2021-07-13 | 一种伏立康唑中间体外消旋体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114057699B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114920729A (zh) * | 2022-07-11 | 2022-08-19 | 天津力生制药股份有限公司 | 一种伏立康唑中间体的合成方法与应用 |
CN115477642A (zh) * | 2022-09-23 | 2022-12-16 | 植恩生物技术股份有限公司 | 一种伏立康唑原料药杂质及其制备方法和用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109705102A (zh) * | 2019-02-19 | 2019-05-03 | 浙江华海立诚药业有限公司 | 伏立康唑及其中间体的制备方法 |
CN110724130A (zh) * | 2019-11-29 | 2020-01-24 | 怀化学院 | 伏立康唑及其中间体的合成方法 |
CN111704606A (zh) * | 2020-06-11 | 2020-09-25 | 广东隆赋药业股份有限公司 | 一种伏立康唑中间体的制备方法 |
-
2021
- 2021-07-13 CN CN202110789834.5A patent/CN114057699B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109705102A (zh) * | 2019-02-19 | 2019-05-03 | 浙江华海立诚药业有限公司 | 伏立康唑及其中间体的制备方法 |
CN110724130A (zh) * | 2019-11-29 | 2020-01-24 | 怀化学院 | 伏立康唑及其中间体的合成方法 |
CN111704606A (zh) * | 2020-06-11 | 2020-09-25 | 广东隆赋药业股份有限公司 | 一种伏立康唑中间体的制备方法 |
Non-Patent Citations (2)
Title |
---|
刘鹰翔.药物合成反应.中国中医药出版社,2017,(第1版),第243页. * |
赵大洲.基础化学实验.天津大学出版社,2020,(第1版),第30-35页. * |
Also Published As
Publication number | Publication date |
---|---|
CN114057699A (zh) | 2022-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114057699B (zh) | 一种伏立康唑中间体外消旋体的制备方法 | |
CN104177272B (zh) | 一种溴芬酸钠的制备方法 | |
KR20130129180A (ko) | 아미노벤조일벤조푸란 유도체의 제조 방법 | |
CN108586374B (zh) | 2-苯基苯并噁唑类化合物的制备方法 | |
CN113880846B (zh) | 一种7-碘吡咯并[2,1-f][1,2,4]三嗪-4-胺的制备方法 | |
CN107935892B (zh) | 一种制备乙二胺基乙磺酸钠的方法 | |
JPS5821658B2 (ja) | エンキセイオキサジンセンリヨウノセイホウ | |
CN110818619B (zh) | 一种n-(3-氯-4-(2-吡啶甲氧基)苯基)-2氰基乙酰胺的合成方法 | |
CN114644612B (zh) | 一种苯二氮杂类神经抑制剂中间体化合物的制备方法 | |
CN113527255A (zh) | 一种氯虫苯甲酰胺中间体的合成方法 | |
CN109422675B (zh) | 一种新型单胺氧化酶抑制剂吗拉贝胺的合成方法 | |
CN106478484B (zh) | 一种制备阿莫曲坦关键中间体的方法 | |
CN118026867B (zh) | 一种制备2-(1r,5s,6s)-6-(氨甲基)-3-乙基双环[3.2.0]庚烷-3-烯-6-乙酸的方法 | |
CN112341413A (zh) | 一种用于合成布瓦西坦的中间体及其制备方法 | |
CN114369069B (zh) | 一种精喹禾灵环合物中间体的制备方法 | |
CN118206469A (zh) | 一种3-羟基-4-(三氟甲基)苯甲腈的合成方法 | |
CN114195684B (zh) | 一种氨基保护基n-取代手性氨基酸的合成方法 | |
CN113880778B (zh) | 一种制备6-氨基-5-硝基喹喔啉的方法 | |
CN113387874B (zh) | 6,6-二烷基哌啶-2-羧酸化合物的合成方法 | |
CN106831739A (zh) | 一种用于合成依匹哌唑的制备方法 | |
CN108017599B (zh) | [3-(胺甲基)-氧杂环丁烷-3-基]氨基甲酸对甲氧基苄酯对氯苯甲酸盐合成方法 | |
CN112110866A (zh) | 一种雷西纳德的制备方法 | |
CN118063443A (zh) | 含氮杂环二酮类化合物、其中间体及其制备方法 | |
CN114249690A (zh) | 一种罗沙司他的合成方法 | |
CN114478417A (zh) | 5-对甲苯基-1,2,4-三嗪-3(2h)-酮的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Yu Hui Inventor after: Wang Yue Inventor after: Zhuang Yujiang Inventor after: Hou Weiwei Inventor after: Liu Haifeng Inventor after: Shao Jin Inventor after: Yu Changquan Inventor before: Yu Hui Inventor before: Yu Changquan Inventor before: Hou Weiwei Inventor before: Liu Haifeng Inventor before: Wang Yue Inventor before: Zhuang Yujiang Inventor before: Shao Jin |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240407 Address after: 710000, 1st floor, Building B2, Tianhaixing Digital Workshop, Fengdong New City, Xi'an City, Shaanxi Province Applicant after: Xi'an Licai Pharmaceutical R&D Co.,Ltd. Country or region after: China Address before: 712000 floor 29, block B, Licai Golden Square, 29 Renmin West Road, Qindu District, Xianyang City, Shaanxi Province Applicant before: Shaanxi Li Cai Pharmaceutical Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |